Sivextro
Total Payments
$62,572
Transactions
3,817
Doctors
2,428
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $35,494 | 2,112 | 1,555 |
| 2021 | $23,147 | 1,463 | 1,092 |
| 2020 | $3,931 | 242 | 230 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $62,572 | 3,817 | 100.0% |
Ad
Manufacturing Companies
- Nabriva Therapeutics, plc $62,572
Product Information
- Type Drug
- Total Payments $62,572
- Total Doctors 2,428
- Transactions 3,817
About Sivextro
Sivextro is a drug associated with $62,572 in payments to 2,428 healthcare providers, recorded across 3,817 transactions in the CMS Open Payments database. The primary manufacturer is Nabriva Therapeutics, plc.
Payment data is available from 2020 to 2022. In 2022, $35,494 was paid across 2,112 transactions to 1,555 doctors.
The most common payment nature for Sivextro is "Food and Beverage" ($62,572, 100.0% of total).